Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Decompensated Cirrhosis With MELD > 9
NCT07652203Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised trial of propranolol in Cirrhosis (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Time from randomization to the occurrence of further decompensation up to 96 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NCT07652203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07652203.